Table 2.
Clinical Quality Outcomes: Estimated Physician-Defined Complexity vs. Outpatient Charlson Score and Estimated Physician-Defined Complexity vs. the Commercial Risk Predictor
| Measure | Physician-Defined Complexity (ePDC) vs. Outpatient Charlson (OCS) | Physician-Defined Complexity (ePDC) vs. Commercial Risk Predictor (CRP) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Complex by | Complex by | |||||||||||
| OCS Only n = 6,691 |
ePDC Only n = 10,725 |
ePDC & OCS n = 10,115 |
CRP Only n = 8,592 |
ePDC Only n= 9,195 |
ePDC & CRP n = 11,645 |
|||||||
| # Eligible Patients | % of follow-up time with incomplete test | # Eligible Patients | % of follow-up time with incomplete test | # Eligible Patients | % of follow-up time with incomplete test | # Eligible Patients | % of follow-up time with incomplete test | # Eligible Patients | % of follow-up time with incomplete test | # Eligible Patients | % of follow-up time with incomplete test | |
| Cancer Screening | ||||||||||||
| Breast Cancer | 2240 | 14.9 | 4549 | 21.4‡ | 2832 | 21.3‡ | 2899 | 15.0 | 3807 | 22.7‡ | 3574 | 20.0 |
| Cervical Cancer | 1468 | 13.3 | 3916 | 17.8‡ | 1607 | 20.1‡ | 2735 | 11.2 | 3178 | 19.4‡ | 2345 | 17.1‡ |
| Colorectal Cancer | 4123 | 18.7 | 6100 | 25.9‡ | 5376 | 23.4 | 4426 | 18.2 | 5416 | 27.0‡ | 6060 | 22.7 |
| Diabetes | ||||||||||||
| LDL ≥ 130 | 1088 | 7.9 | 3159 | 12.4‡ | 4887 | 8.3 | 966 | 9.0 | 3133† | 11.8‡ | 4913 | 8.8 |
| A1C ≥ 9 | 1089 | 8.1 | 3184 | 15.6‡ | 4912 | 10.4 | 972 | 6.9 | 3162 | 15.9‡ | 4934 | 10.3 |
| Vascular Disease | ||||||||||||
| LDL ≥ 130 | 1348 | 5.7 | 996 | 10.4‡ | 3593 | 6.7 | 1315 | 5.3 | 1128 | 9.5 | 3461 | 6.8* |
*p < 0.05, †p < 0.01, ‡p < 0.001
LDL = Low-Density Lipoprotein, A1C = Hemoglobin A1c